Distribution of systemic clarithromycin to gingiva.
BACKGROUND
Aggressive and recurrent forms of periodontitis are associated with infections by Aggregatibacter actinomycetemcomitans (previously Actinobacillus actinomycetemcomitans) and Porphyromonas gingivalis. Because these pathogens invade tissue, they are difficult to eliminate by root planing alone. The use of systemic antibiotics in conjunction with root planing significantly enhances clinical and microbiologic treatment outcomes. Although it is not widely prescribed by periodontists, clarithromycin is potentially useful because it is taken up by host cells and has favorable antimicrobial activity.


METHODS
Experimental gingivitis was induced in eight healthy subjects at one randomly selected maxillary posterior site. The contralateral maxillary site served as the healthy control. Thereafter, subjects were administered six doses of clarithromycin, 500 mg, every 12 hours. Blood was then drawn, and samples of gingiva were harvested from both sites. The samples were extracted, and clarithromycin content was analyzed by liquid chromatography.


RESULTS
Mean clarithromycin concentrations in healthy control and inflamed gingiva (2.4 and 3.0 microg/g, respectively) were significantly higher than in serum (0.5 microg/ml; P <0.05). Clarithromycin levels at control and gingivitis sites were higher than serum by 5.7- and 7.0-fold, respectively (difference between sites was significant; P = 0.02). At control sites, a significant decrease in gingival crevicular fluid flow rate was evident at the conclusion of the clarithromycin regimen (P = 0.018).


CONCLUSIONS
Clarithromycin can attain higher levels in gingiva than serum and reach higher levels in inflamed gingiva than in healthy gingiva. Its distribution profile seems to be suitable for the treatment of periodontitis. The reduction in crevicular fluid flow at control sites suggested that clarithromycin may produce anti-inflammatory effects.
Burrell
Renita C
RC
Section of Periodontology, College of Dentistry, The Ohio State University, 305 W. 12th Street, Columbus, OH 43210, USA.
Walters
John D
JD
D000328:Adult; D000900:Anti-Bacterial Agents / Q000097:blood / Q000493:pharmacokinetics* / Q000627:therapeutic use; D000893:Anti-Inflammatory Agents / Q000493:pharmacokinetics; D017291:Clarithromycin / Q000097:blood / Q000493:pharmacokinetics* / Q000627:therapeutic use; D015331:Cohort Studies; D003774:Dental Plaque Index; D005260:Female; D005500:Follow-Up Studies; D005881:Gingiva / Q000378:metabolism*; D005883:Gingival Crevicular Fluid / Q000378:metabolism; D005891:Gingivitis / Q000097:blood / Q000188:drug therapy / Q000378:metabolism; D006801:Humans; D008137:Longitudinal Studies; D008297:Male; D010512:Periodontal Index; D011446:Prospective Studies
D000900:Anti-Bacterial Agents; D000893:Anti-Inflammatory Agents; D017291:Clarithromycin
J Periodontol. 1965 May-Jun;36:177-87
14296927
Curr Pharm Des. 2004;10(25):3045-53
15544496
Acta Odontol Scand. 1963 Dec;21:533-51
14121956
J Antimicrob Chemother. 1993 Jun;31 Suppl E:5-16
8396096
Antimicrob Agents Chemother. 1990 Jun;34(6):1056-60
2168141
Chemotherapy. 1993 Nov-Dec;39(6):416-23
8222870
Int J Antimicrob Agents. 2001;18 Suppl 1:S11-5
11574189
J Antimicrob Chemother. 2005 Jan;55(1):10-21
15590715
J Clin Periodontol. 1996 Nov;23(11):998-1003
8951627
Acta Odontol Scand. 1964 Feb;22:121-35
14158464
J Periodontol. 2004 Dec;75(12):1663-7
15732869
Int J Antimicrob Agents. 2002 Nov;20(5):348-60
12431870
J Chemother. 1997 Feb;9(1):23-31
9106014
J Dent Res. 2008 Aug;87(8):777-81
18650552
Chest. 2004 Feb;125(2 Suppl):52S-60S; quiz 60S-61S
14872001
Antimicrob Agents Chemother. 1989 Mar;33(3):277-82
2543276
J Antimicrob Chemother. 1988 Dec;22(6):923-33
2977384
Antimicrob Agents Chemother. 1999 Nov;43(11):2801-5
10543769
Int J Antimicrob Agents. 2006 Sep;28(3):244-8
16875802
J Periodontal Res. 1996 Aug;31(6):441-3
8884638
Antimicrob Agents Chemother. 1992 Jun;36(6):1241-3
1329617
Antimicrob Agents Chemother. 1998 Nov;42(11):3000-1
9797240
J Periodontol. 2004 Jan;75(1):169-75
15025229
J Am Dent Assoc. 1999 Sep;130(9):1341-3
10492541
Klin Med (Mosk). 2007;85(6):47-50
17682493
J Clin Periodontol. 2002 Jan;29(1):54-61
11846850
Pharmacol Res. 2001 Dec;44(6):451-4
11735349
Res Commun Mol Pathol Pharmacol. 2001;110(3-4):183-208
12760488
J Periodontol. 2004 Nov;75(11):1553-65
15633334
Eur J Clin Microbiol Infect Dis. 1991 Oct;10(10):828-33
1662626
Oral Microbiol Immunol. 1993 Oct;8(5):325-6
8265209
J Periodontol. 2005 Mar;76(3):426-36
15857078
J Periodontol. 1992 Sep;63(9):743-7
1474474
J Chromatogr B Biomed Sci Appl. 1998 Dec 11;720(1-2):89-97
9892071
J Periodontol. 1999 Sep;70(9):960-6
10505797
Clin Pharmacokinet. 1999 Nov;37(5):385-98
10589373